BioCentury
ARTICLE | Clinical News

Esmya ulipristal Acetate regulatory update

December 19, 2011 8:00 AM UTC

EMA's CHMP issued a positive opinion recommending approval of Esmya ulipristal acetate from Gedeon's Richter's PregLem S.A. subsidiary to treat moderate to severe uterine fibroids in women of reprodu...